首页/数据集/Median time to onset of clinical signs in placebo group-PEP study.

Median time to onset of clinical signs in placebo group-PEP study.

NIAID Data Ecosystem2026-03-10 收录

数据链接：

https://figshare.com/articles/dataset/Median_time_to_onset_of_clinical_signs_in_placebo_group-PEP_study_/5626546 数据链接链接失效反馈

官方服务：

资源简介：

Median time to onset of clinical signs in placebo group-PEP study.

应用场景：

创建时间：

2017-11-23

临床试验终点分析

敏感性分析

an = Day 3 PP population minus six patients (two adults, four children) with ‘poor model fit’ due to the model being inadequate to fit their data. P values that are statistically significant are in it

NIAID Data Ecosystem50

Results for the primary endpoint – effects on the hospitalization rate in the ITT and R-PP-CC population.

临床试验终点分析

住院率疗效评估

Results for the primary endpoint – effects on the hospitalization rate in the ITT and R-PP-CC population.

Figshare2025-05-15 更新30

Baseline characteristics and survival outcomes.

肿瘤生存分析

临床试验终点分析

*P value was based on Cochran-Mantel-Haenszel test for response and log-rank test for PFS and OS.

NIAID Data Ecosystem20

PFS and OS analysis with Kaplan-Meier method and log-rank test.

肿瘤生存分析

临床试验终点分析

*Factors at p<0.1 level enter into Cox regression analysis. P-values for further analysis (p<0.1) are in bold. **95% CI cannot be calculated as 3 out of 5 individuals in the subgroup are censored. ***

NIAID Data Ecosystem40

Comparison between treatments vs. corresponding Control values at CSR/END midpoint.

临床试验终点分析

治疗效应比较

Comparison between treatments vs. corresponding Control values at CSR/END midpoint.

NIAID Data Ecosystem20